Articles Archives - Page 534 of 733

ThursdayFeb 20, 2020 12:00 pm

SinglePoint Inc. (SING) Subsidiary Reports Continued Growth as Company Kicks Off 2020 Initiatives

SING’s current strategy includes focused marketing, sales-development initiatives Company “strongly committed” to continued development, improvement of Direct Solar America subsidiary SEIA dubs 2020s the solar+ decade; SING set to capitalize on solar becoming leading source of new-energy generation Following a week during which its subsidiary Direct Solar America reported increased growth in terms of new contract development, SinglePoint Inc. (OTCQB: SING) notes that the company’s 2020 strategy – which includes new marketing and sales development initiatives – is starting to take shape (http://ibn.fm/FRG97). Designed primarily around Direct Solar America, those initiatives are comprised of starting new canvassing teams, improving customer service…

ThursdayFeb 20, 2020 11:03 am

National Storm Recovery Inc. (NSRI) is “One to Watch”

More than 40 years of next level experience with mulch manufacturing, colorant production, product innovation and treating/caring for trees and tree debris recycling. Services include tree removal, trimming, grapple hauling, land clearing, stump grinding, mulch processing, colorant production and packaging, transportation and distribution. Acquisition of Mulch Manufacturing provides NSRI a significantly larger footprint nationally and abroad. Mulch Manufacturing maintains its historical contracts with big box retailers nationally for bagged mulch sales. NSRI benefits from a competitive advantage over other mulch manufacturers because the acquisition of mulch feedstock drives revenue instead of simply being a cost of goods sold. Environmentally responsible…

WednesdayFeb 19, 2020 11:41 am

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Advances Precision Therapeutics by Learning Cancer Behavior, Improving Outcomes

Predictive Oncology subsidiary TumorGenesis developing faster, less costly and more accurate PDx cancer models that better mimic patient’s tumor TumorGenesis revolutionary technology will provide pharmaceuticals with quicker, more effective drug development while significantly improving patient outcomes POAI to begin sales of TumorGenesis’ innovative culture media in the first half of 2020 TumorGenesis, a flagship subsidiary of Predictive Oncology Inc. (NASDAQ: POAI), has made concrete steps in identifying and separating cancer-related biomarkers, which is likely to speed the development of new and effective therapeutics. TumorGenesis media are specially formulated to help researchers isolate and maintain the unique histological and basic biological…

WednesdayFeb 19, 2020 10:43 am

Trxade Group Inc. (NASDAQ: MEDS) Uplists to Nasdaq, Expects Gross Proceeds of $5.2M from Common Stock Sale

Trxade announces pricing of a firm commitment public offering of 806,452 shares of its common stock Proceeds to be used as working capital and to fund future acquisitions Company’s B2B online purchasing platform currently has 11,900 pharmacies registered and is registering 100+ New pharmacies per month Trxade Group Inc. (NASDAQ: MEDS), an integrated drug delivery, procurement, and healthcare platform that offers healthcare buyers and sellers of pharmaceuticals increased profit margins, announced that its common stock has begun trading on the Nasdaq Capital Market under new ticker symbol ‘MEDS’, as of February 13, 2020. The company’s common stock will cease trading…

TuesdayFeb 18, 2020 1:01 pm

SRAX Inc. (NASDAQ: SRAX) Reveals Strategic Plans for 2020 as Exclusive Platforms Start Generating Multiple Recurring Revenue Streams

SRAX CEO discusses company’s milestone achievements in 2019 Two flagship products – BIGtoken and SRAX IR – are generating multiple recurring revenue streams SRAX is strategically positioned for strong 2020 as proprietary products start contributing to the top line Company moves from development cycle to revenue cycle, anticipates 2020 growth In an exclusive interview with NNW’s Stuart Smith, SRAX Inc. (NASDAQ: SRAX) CEO Chris Miglino discusses the company’s milestone achievements in 2019 as well as its ambitious plans for 2020 to harness the brand recognition built on the emerging regulation underpinning consumer data protection (http://ibn.fm/G72dC). "That was a big year for…

TuesdayFeb 18, 2020 12:32 pm

Nightfood Holdings Inc.’s (NGTF) Better-For-You Ice Cream Now Being Recommended to Pregnant Women by Care Providers

Nightfood has superior nutritional profile for mothers-to-be Award-winning ice cream increasingly recommended to pregnant women by service providers. Nightfood aims to leverage untapped pregnancy market of up to 3 million women to accelerate national supermarket rollout Nightfood Holdings Inc. (OTCQB: NGTF) is changing the conversation around ice cream through its subsidiary Nightfood Inc., creator of an award-winning, nutrient-rich ice cream that is taking the pregnancy community by storm. With its unique and healthier nutritional profile, Nightfood is being recommended to pregnant women by their providers as a better option when pregnancy cravings inevitably hit. Nightfood is in position to dominate…

TuesdayFeb 18, 2020 11:24 am

ChineseInvestors.com Inc. (CIIX) Subsidiary Leveraging Untapped Chinese Market for Sale of Hemp-Based Nutrition, Cosmetic Products

CBD Biotech seizing immense opportunities in untapped CBD Chinese market CIIX operates both online, physical CBD stores in addition to developing first Chinese, CBD-based social media app CIIX’s hemp-based products fully legal in China with plans for further development, Nasdaq IPO this year ChineseInvestors.com Inc. (OTCQB: CIIX), a leading U.S.-based financial consultancy for Chinese-speaking investors, is positioning its subsidiary, CBD Biotech Inc., as a leader in the Chinese-based CBD market through increased development of legal hemp-based products. Clinically shown to help with anxiety and stress-related disorders (http://ibn.fm/dbNam), CBD-based products may be helpful for dealing with the coronavirus outbreak, CIIX CEO Warren…

FridayFeb 14, 2020 11:54 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Demonstrates Applicability of Drug Delivery Platform Through Relationships with Fortune 500 Leaders

Lexaria’s DehydraTECH(TM) drug delivery platform a feasible and healthier alternative to other delivery methods The fast-acting, high absorption technology improves dipping experience and consumer satisfaction Company expects to more than double its 2019 revenue this year, will pursue a new capital markets strategy to qualify for listing on a nationally recognized U.S. exchange Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms and one of the few companies active in the field of cannabis to have developed formal relationships with Fortune 500 industry leaders, is experiencing strong demand from many companies requesting pre-processed DehydraTECH(TM)-enhanced bulk powders.…

Site Search

Company Search

Category: Articles